These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12876523)
1. [Promising results with the anti-HIV vaccine]. Katlama C Presse Med; 2003 Jun; 32(21):964. PubMed ID: 12876523 [No Abstract] [Full Text] [Related]
2. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068. Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I; J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption. Harrer E; Bäuerle M; Ferstl B; Chaplin P; Petzold B; Mateo L; Handley A; Tzatzaris M; Vollmar J; Bergmann S; Rittmaier M; Eismann K; Müller S; Kalden JR; Spriewald B; Willbold D; Harrer T Antivir Ther; 2005; 10(2):285-300. PubMed ID: 15865223 [TBL] [Abstract][Full Text] [Related]
4. Just (don't) do it. Schooley RT J Clin Invest; 1993 Aug; 92(2):535. PubMed ID: 8349794 [No Abstract] [Full Text] [Related]
5. First UK trial of AIDS vaccine approved. Concar D Nature; 1990 Jul; 346(6282):303. PubMed ID: 2197559 [No Abstract] [Full Text] [Related]
6. Merck's HIV vaccine flop brings vectors under closer scrutiny. Ledford H Nat Biotechnol; 2008 Jan; 26(1):3-4. PubMed ID: 18182999 [No Abstract] [Full Text] [Related]
7. First AIDS vaccine trial launched. Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708 [No Abstract] [Full Text] [Related]
8. New hope for an AIDS vaccine. Robinson HL Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995 [TBL] [Abstract][Full Text] [Related]
9. Scientific and policy challenges to development of an AIDS vaccine. Berkley SF; Koff WC Lancet; 2007 Jul; 370(9581):94-101. PubMed ID: 17617277 [No Abstract] [Full Text] [Related]
10. Tepid endorsement for HIV vaccine trial. Science; 1995 Feb; 267(5200):966. PubMed ID: 7863340 [No Abstract] [Full Text] [Related]
11. Some statistical issues in HIV vaccine trials. Rida WN; Lawrence DN Stat Med; 1994 Oct 15-30; 13(19-20):2155-77. PubMed ID: 7846417 [TBL] [Abstract][Full Text] [Related]
12. [Controversies concerning the use of zidovudine in the treatment of asymptomatic HIV+ subjects with a low number of CD4+ lymphocytes]. Sarmati L; Vella S; Rocchi G Medicina (Firenze); 1990; 10(2):195-7. PubMed ID: 2273959 [No Abstract] [Full Text] [Related]
13. Zidovudine for symptomless HIV infection. Lancet; 1990 Apr; 335(8693):821-2. PubMed ID: 1969561 [No Abstract] [Full Text] [Related]
14. Steady but slow progress toward AIDS vaccine. Minn Med; 1993 Aug; 76(8):38-9. PubMed ID: 8371702 [No Abstract] [Full Text] [Related]
20. [Prospects in the treatment of AIDS. I. Research trends]. Grieb P Pol Arch Med Wewn; 1992; 87(4-5):306-15. PubMed ID: 1381824 [No Abstract] [Full Text] [Related] [Next] [New Search]